Q3 FY2026 · ended Sep 30, 2026 · Revenue $98.29M, +18.0% YoY · Filed Nov 4, 2026
PROCEPT BioRobotics Corporation (PRCT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $98.3 million and a net loss of $26.5 million. Free cash flow was -$9.7 million. As of Sep 30, 2026 it held $218.4 million in cash and investments and $77.0 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PRCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1588978
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $98.3M | $94.5M | $83.1M | $76.4M | $83.3M |
| Operating income | -$27.4M | -$27.4M | -$32.6M | -$31.0M | -$23.2M |
| Net income | -$26.5M | -$26.9M | -$31.6M | -$29.8M | -$21.4M |
| Diluted EPS | -$0.46 | -$0.47 | -$0.56 | -$0.53 | -$0.38 |
| Operating cash flow | -$9.0M | -$19.3M | -$38.1M | -$10.3M | -$6.6M |
| Free cash flow | -$9.7M | -$22.2M | -$41.0M | -$12.2M | -$9.5M |
| Total assets | $473.8M | $479.4M | $487.1M | $508.1M | $511.5M |
| Total liabilities | $144.9M | $139.3M | $139.4M | $142.2M | $131.3M |
| Stockholders' equity | $328.9M | $340.1M | $347.7M | $365.9M | $380.3M |
| Cash and investments | $218.4M | $227.9M | $245.6M | $286.5M | $294.3M |
| Total debt | $77.0M | $77.5M | $78.0M | $78.5M | $78.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 24, 2026 | Sep 23, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
All 397 PROCEPT BioRobotics Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.